Concizumab, CAS [[1312299-39-0]]

Produktübersicht

• Artikelname: Concizumab, CAS [[1312299-39-0]]
• Artikelnummer: TGM-T77373
• Hersteller Artikelnummer: T77373
• Alternativnummer: TGM-T77373-1MG,TGM-T77373-5MG,TGM-T77373-10MG,TGM-T77373-25MG,TGM-T77373-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: mAb 2021 , NN 7415

Produktbeschreibung

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site. Injections of Concizumab increase thrombin in blood, thereby preventing and treating hemophilia.

Produkteigenschaften

• Reinheit: 95.00%
• CAS Nummer: [1312299-39-0]
• Target-Kategorie: Others|||Factor Xa